Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in XWEL — XWELL, Inc.

CIK 1214717 BOSTON, MA
Back to XWEL Full portfolio

Position in XWEL

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$58,311
-$19,341 QoQ
Shares Held
56,069
-17.0% QoQ
Ownership
0.653%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 23 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XWEL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $16,518,034,912 across 38 Diagnostics & Research names. XWEL ranks #36 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 8,382,401 $4,202,600,564
2 DHR
Danaher Corp /De/
 14,280,335 $2,720,118,210
3 IDXX
Idexx Laboratories Inc /De
 2,562,886 $1,349,205,704
4 A
Agilent Technologies, Inc.
 7,595,644 $1,008,929,392
5 WAT
Waters Corp /De/
 2,636,146 $988,660,195
6 IQV
Iqvia Holdings Inc.
 4,454,134 $860,627,771
7 MTD
Mettler Toledo International Inc/
 612,153 $782,031,578
8 NTRA
Natera, Inc.
 2,750,013 $746,491,028

All Filings in XWEL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $58,311 56,069
2026-03-31 $77,652 67,524
2025-12-31 $20,980 45,611
2025-09-30 $46,463 46,934
2025-06-30 $43,178 46,934
2025-03-31 $49,390 48,423
2024-12-31 $80,881 53,564
2024-09-30 $92,657 53,560
2024-06-30 $83,496 46,387
2024-03-31 $82,002 48,522
2023-12-31 $84,428 48,522
2023-09-30 $109,176 48,523
2023-06-30 $196,693 983,465
2023-03-31 $374,956 1,041,547
2022-12-31 $374,956 1,041,547
2022-09-30 $803,731 1,043,807
2022-06-30 $757,849 1,098,333
2022-03-31 $1,236,138 1,093,928
2021-12-31 $2,030,176 1,005,038
2021-09-30 $1,468,256 998,814
2021-06-30 $1,358,740 882,299
2021-03-31 $1,365,182 741,947
2020-12-31 $556,423 467,583
2020-09-30 $692,669 351,609
2020-06-30 $740,557 176,744